Cargando…
Peri-Operative Anaphylaxis—An Investigational Challenge
Patients with suspected peri-operative anaphylaxis (POP) require thorough investigation to identify underlying trigger(s) and enable safe anesthesia for subsequent surgery. The changing epidemiology of POP has been striking. Previous estimates of the incidence of POP have ranged between 1:6,000 and1...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549036/ https://www.ncbi.nlm.nih.gov/pubmed/31191519 http://dx.doi.org/10.3389/fimmu.2019.01117 |
_version_ | 1783423922452037632 |
---|---|
author | Misbah, Siraj A. Krishna, Mamidipudi Thirumala |
author_facet | Misbah, Siraj A. Krishna, Mamidipudi Thirumala |
author_sort | Misbah, Siraj A. |
collection | PubMed |
description | Patients with suspected peri-operative anaphylaxis (POP) require thorough investigation to identify underlying trigger(s) and enable safe anesthesia for subsequent surgery. The changing epidemiology of POP has been striking. Previous estimates of the incidence of POP have ranged between 1:6,000 and1:20,000 anesthetics, but more recent data from France and the United Kingdom suggest an estimated incidence of 1:10,000. Other important changes include a change in the hierarchy of well-recognized triggers, with antibiotics (beta-lactams) supplanting neuromuscular blockers (NMB) as the leading cause of POP. The emergence of chlorhexidine, patent blue dye, and teicoplanin as important triggers have also been noteworthy findings. The mainstay of investigation revolves around critical analysis of the time-line of events leading up to anaphylaxis coupled with judicious skin testing. Skin tests have limitations with respect to unknown predictive values for most drugs/agents and therefore, knowledge of background positivity in healthy controls, test characteristics of individual drugs and the use of non-irritant concentrations is essential to avoid both false-positive and false-negative results. Specific IgE assays for individual drugs are available only for a limited number of agents and are not a substitute for skin testing. Acute serum total tryptase has a high specificity and positive predictive value in IgE-mediated POP anaphylaxis but is limited by its moderate sensitivity and negative predictive value. Planning for safe anesthesia in this group of patients is particularly challenging and consequently anesthetists need to be alert to the possibility of repeat episodes of anaphylaxis. Because of the limitations of current investigations for POP, collecting systematic data on the outcome of repeat anesthesia is valuable in validating current investigatory approaches. This paper reviews the changing epidemiology of POP with reference to the main triggers, and the investigation and outcome of subsequent anesthesia. |
format | Online Article Text |
id | pubmed-6549036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65490362019-06-12 Peri-Operative Anaphylaxis—An Investigational Challenge Misbah, Siraj A. Krishna, Mamidipudi Thirumala Front Immunol Immunology Patients with suspected peri-operative anaphylaxis (POP) require thorough investigation to identify underlying trigger(s) and enable safe anesthesia for subsequent surgery. The changing epidemiology of POP has been striking. Previous estimates of the incidence of POP have ranged between 1:6,000 and1:20,000 anesthetics, but more recent data from France and the United Kingdom suggest an estimated incidence of 1:10,000. Other important changes include a change in the hierarchy of well-recognized triggers, with antibiotics (beta-lactams) supplanting neuromuscular blockers (NMB) as the leading cause of POP. The emergence of chlorhexidine, patent blue dye, and teicoplanin as important triggers have also been noteworthy findings. The mainstay of investigation revolves around critical analysis of the time-line of events leading up to anaphylaxis coupled with judicious skin testing. Skin tests have limitations with respect to unknown predictive values for most drugs/agents and therefore, knowledge of background positivity in healthy controls, test characteristics of individual drugs and the use of non-irritant concentrations is essential to avoid both false-positive and false-negative results. Specific IgE assays for individual drugs are available only for a limited number of agents and are not a substitute for skin testing. Acute serum total tryptase has a high specificity and positive predictive value in IgE-mediated POP anaphylaxis but is limited by its moderate sensitivity and negative predictive value. Planning for safe anesthesia in this group of patients is particularly challenging and consequently anesthetists need to be alert to the possibility of repeat episodes of anaphylaxis. Because of the limitations of current investigations for POP, collecting systematic data on the outcome of repeat anesthesia is valuable in validating current investigatory approaches. This paper reviews the changing epidemiology of POP with reference to the main triggers, and the investigation and outcome of subsequent anesthesia. Frontiers Media S.A. 2019-05-29 /pmc/articles/PMC6549036/ /pubmed/31191519 http://dx.doi.org/10.3389/fimmu.2019.01117 Text en Copyright © 2019 Misbah and Krishna. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Misbah, Siraj A. Krishna, Mamidipudi Thirumala Peri-Operative Anaphylaxis—An Investigational Challenge |
title | Peri-Operative Anaphylaxis—An Investigational Challenge |
title_full | Peri-Operative Anaphylaxis—An Investigational Challenge |
title_fullStr | Peri-Operative Anaphylaxis—An Investigational Challenge |
title_full_unstemmed | Peri-Operative Anaphylaxis—An Investigational Challenge |
title_short | Peri-Operative Anaphylaxis—An Investigational Challenge |
title_sort | peri-operative anaphylaxis—an investigational challenge |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549036/ https://www.ncbi.nlm.nih.gov/pubmed/31191519 http://dx.doi.org/10.3389/fimmu.2019.01117 |
work_keys_str_mv | AT misbahsiraja perioperativeanaphylaxisaninvestigationalchallenge AT krishnamamidipudithirumala perioperativeanaphylaxisaninvestigationalchallenge |